Al-Qaisi, S. K., Salman, O. D., Ibrahim, S. K., & Mohsein, O. A. (2025). The interaction between cytokine profiles and Epstein-Barr virus-induced immune response. Regulatory Mechanisms in Biosystems, 16(4), e25208.

Arif, A. I., Rmaidh, A. Y., Qaddoori, H. T., & Mohammad, S. Q. (2025). Importance of testosterone and cortisol in prediabetic and diabetic male patients in Diyala Governorate (Iraq). Regulatory Mechanisms in Biosystems, 16(2), e25070.

Baluku, J. B., Nalwanga, R., Kazibwe, A., Olum, R., Nuwagira, E., Mugenyi, N., Mulindwa, F., & Bongomin, F. (2024). Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda. Lipids in Health and Disease, 23, 65.

Bewket, G., Kiflie, A., Tajebe, F., Abate, E., Schön, T., & Blomgran, R. (2022). Helminth species dependent effects on Th1 and Th17 cytokines in active tuberculosis patients and healthy community controls. PLoS Neglected Tropical Diseases, 16(8), e0010721.

Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., Kapata, N., Mfinanga, S., Hasnain, S. E., Katoto, P. D. M. C., Bulabula, A. N. H., Sam-Agudu, N. A., Nachega, J. B., Tiberi, S., McHugh, T. D., Abubakar, I., & Zumla, A. (2021). Global tuberculosis report 2020 – reflections on the global TB burden, treatment and prevention efforts. International Journal of Infectious Diseases, 113, S7–S12.

Chamoun, M. N., Blumenthal, A., Sullivan, M. J., Schembri, M. A., & Ulett, G. C. (2018). Bacterial pathogenesis and interleukin-17: Interconnecting mechanisms of immune regulation, host genetics, and microbial virulence that influence severity of infection. Critical Reviews in Microbiology, 44(4), 465–486.

Diatlova, A., Linkova, N., Lavrova, A., Zinchenko, Y., Medvedev, D., Krasichkov, A., Polyakova, V., & Yablonskiy, P. (2023). Molecular markers of early immune response in tuberculosis: Prospects of application in predictive medicine. International Journal of Molecular Sciences, 24(17), 13261.

Feng, J.-Y., Ho, L.-I., Chuang, F.-Y., Pan, S.-W., Chen, Y.-Y., Tung, C.-L., Li, C.-P., & Su, W.-J. (2021). Depression and recovery of IL-17A secretion in mitogen responses in patients with active tuberculosis – a prospective observational study. Journal of the Formosan Medical Association, 120(4), 1080–1089.

Gaines, S. W. (2022). Tails of twists and turns: Using zebrafish to unravel neutrophil chromatin remodelling. Doctoral dissertation. University of Sheffield, Sheffield.

Ghanavi, J., Farnia, P., Farnia, P., & Velayati, A. A. (2021). The role of interferon-gamma and interferon-gamma receptor in tuberculosis and nontuberculous mycobacterial infections. The International Journal of Mycobacteriology, 10(4), 349–357.

Gurczynski, S. J., & Moore, B. B. (2018). IL-17 in the lung: The good, the bad, and the ugly. American Journal of Physiology – Lung Cellular and Molecular Physiology, 314(1), L6–L16.

Khaleel Ibrahim, S., Salim Badr, Z., Saleh Jaleel, I., & Mohammad, S. (2025). Comparative oral colonization for Streptococcus mutans and Candida among caries-affected individuals: A cross-sectional study. Microbes and Infectious Diseases, in press.

Khanna, H., Gupta, S., & Sheikh, Y. (2024). Cell-mediated immune response against Mycobacterium tuberculosis and its potential therapeutic impact. Journal of Interferon and Cytokine Research, 44(6), 244–259.

Landy, E., Carol, H., Ring, A., & Canna, S. (2023). Biological and clinical roles of IL-18 in inflammatory diseases. Nature Reviews Rheumatology, 20(1), 33–47.

Liu, Q.-X., Tang, D.-Y., Xiang, X., & He, J.-Q. (2022). Associations between nutritional and immune status and clinicopathologic factors in patients with tuberculosis: A comprehensive analysis. Frontiers in Cellular and Infection Microbiology, 12, 1013751.

Lu, L. L., Smith, M. T., Yu, K. K. Q., Luedemann, C., Suscovich, T. J., Grace, P. S., Cain, A., Yu, W. H., McKitrick, T. R., Lauffenburger, D., Cummings, R. D., Mayanja-Kizza, H., Hawn, T. R., Boom, W. H., Stein, C. M., Fortune, S. M., Seshadri, C., & Alter, G. (2019). IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure. Nature Medicine, 25(6), 977–987.

Ludi, Z., Sule, A. A., Samy, R. P., Putera, I., Schrijver, B., Hutchinson, P. E., Gunaratne, J., Verma, I., Singhal, A., Nora, R. L. D., van Hagen, P. M., Dik, W. A., Gupta, V., & Agrawal, R. (2023). Diagnosis and biomarkers for ocular tuberculosis: From the present into the future. Theranostics, 13(7), 2088–2113.

Malik, A. W., Mohsen, S. M., Mohsen, A. K., Mohammad, S. Q., & Mohsein, O. A. (2025). Bacterial strains isolated from sinusitis infections and their drug resistance profiles in Nasiriyah (Iraq). Regulatory Mechanisms in Biosystems, 16(2), e25049.

Mannion, J. M., McLoughlin, R. M., & Lalor, S. J. (2022). The airway microbiome-IL-17 axis: A critical regulator of chronic inflammatory disease. Clinical Reviews in Allergy and Immunology, 64(2), 161–178.

Ong, C. W. M., Migliori, G. B., Raviglione, M., MacGregor-Skinner, G., Sotgiu, G., Alffenaar, J.-W., Tiberi, S., Adlhoch, C., Alonzi, T., Archuleta, S., Brusin, S., Cambau, E., Capobianchi, M. R., Castilletti, C., Centis, R., Cirillo, D. M., D’Ambrosio, L., Delogu, G., Esposito, S. M. R., … Goletti, D. (2020). Epidemic and pandemic viral infections: Impact on tuberculosis and the lung. European Respiratory Journal, 56(4), 2001727.

Patil, K., Bagade, S., Bonde, S., Sharma, S., & Saraogi, G. (2018). Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities. Biomedicine and Pharmacotherapy, 99, 735–745.

Shen, H., & Chen, Z. W. (2017). The crucial roles of Th17-related cytokines / signal pathways in M. tuberculosis infection. Cellular and Molecular Immunology, 15(3), 216–225.

Ward, J. D., Cornaby, C., & Schmitz, J. L. (2021). Indeterminate QuantiFERON Gold Plus results reveal deficient interferon gamma responses in severely ill COVID-19 patients. Journal of Clinical Microbiology, 59(10), 10.1128/jcm.00811-21.

Zhang, X., Sun, Y., He, C., Qiu, X., Zhou, D., Ye, Z., Long, Y., Tang, T., Su, X., & Ma, J. (2018). The immune characterization of interferon-β responses in tuberculosis patients. Microbiology and Immunology, 62(4), 281–290.